Advertisement

Chronic Mononucleosis

  • Martin Tobi
  • Abraham Morag

Abstract

Since its discovery in 1964 (1) and implication as the main cause of the infectious mononucleosis (IM) syndrome (2), the Epstein-Barr virus (EBV) has become a common archetype of human latent viral infections (3). This has been ascribed to its infection of B lymphocytes (4) and a resultant permanent viral carrier state (3). These genome carrying cells may give rise to continuous EBV-containing lymphoblastoid cell lines in in vitro cultures established from the peripheral blood and lymph node lymphocytes of seropositive individuals (5). With the characterization of the specific antibody responses in IM (6), their application in the elucidation of atypical cases of EBV infection became evident (7), particularly in children (8) and in 50–60% of adults where the minimal criteria for the diagnosis of IM (9) are not fulfilled (10,11). Given the high incidence of exposed individuals (80% by late adolescence), the recognized tendency of herpes viruses to reactivation (3), the persistent carrier state, and the predisposition to atypical infections, it might be expected that recurrent or prolonged atypical EBV infections would be commonly reported.

Keywords

Infectious Mononucleosis Atypical Lymphocyte Viral Capsid Antigen Serological Profile Prolonged Illness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Epstein, M.A., Achong, B.G., and Barr, Y.M. Virus particle in cultured lymphoblasts from Burkitt’s lymphoma. Lancet, i:702, 1964.CrossRefGoogle Scholar
  2. 2.
    Henle, G., Henle, W., and Diehl, V. Relation of Burkitt’s tumour associated with herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA, 59:94, 1968.PubMedCrossRefGoogle Scholar
  3. 3.
    Epstein, M.A. and Achong, B.G. Various forms of EBV infection in man: estalished facts and a general concept. Lancet, ii:836, 1973.CrossRefGoogle Scholar
  4. 4.
    Pattengale, P.K., Smith, R.W., and Gerber, P. Selective transformation of B lymphocytes by EB virus. Lancet, ii:93, 1973.CrossRefGoogle Scholar
  5. 5.
    Nilsson, K., Klein, G., Henle, W., and Henle, G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer, 8:443, 1971.PubMedGoogle Scholar
  6. 6.
    Henle, W., Henle, G.E., and Horwitz, C.A. Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Human Path., 5:551, 1974.CrossRefGoogle Scholar
  7. 7.
    Hallee, T.J., Evans, A.S., Niederman, J.C., Brooks, C.M., and Voegtly, J.H. IM at the U.S. military academy. Yale J. Biol. Med., 3:182, 1974.Google Scholar
  8. 8.
    Karzon, D.T. Infectious mononucleosis. Adv. Pediat., 22:231, 1976.Google Scholar
  9. 9.
    Horwitz, C.A. Practical approach to the diagnosis of infectious mononucleosis. Postgraduate Med., 65:179, 1979.Google Scholar
  10. 10.
    Niederman, J.C., Evans, A.S., Subrahmanyah, L., and McCollum, R.W. Prevalence, incidence and persistence of EB virus antibody in young adults. N. Engl. J. Med., 282:361, 1970.PubMedCrossRefGoogle Scholar
  11. 11.
    Joint investigation by University Health Physicians and P.H.L.S. Laboratories. Infectious mononucleosis and its relationship to EBV antibody. Br. Med. J., 4:643, 1971.CrossRefGoogle Scholar
  12. 12.
    Paterson, J.K. and Pinninger, J.L. Case of recurrent infectious mononucleosis. Br. Med. J., 2:476, 1955.PubMedCrossRefGoogle Scholar
  13. 13.
    Bender, C.E. Recurrent mononucleosis. J. Am. Med. Assoc., 182:954, 1962.CrossRefGoogle Scholar
  14. 14.
    Kaufman, R.E. Recurrences of infectious mononucleosis. Amer. Practit., 1:673, 1950.Google Scholar
  15. 15.
    Chang, R.S. EBV virus-seropositive person is susceptible to infectious mononucleosis. N. Engl. J. Med., 292:925, 1975.PubMedGoogle Scholar
  16. 16.
    Stevens, D.A., Pry, T.W., and Manaker, R.A. Infectious mononucleosis — Always a primary infection with herpestype virus? J. Natl. Cancer Inst., 44:533, 1970.PubMedGoogle Scholar
  17. 17.
    Horwitz, C.A., Henle, W., Henle, G. et al. Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the EB virus-induced early antigen complex. Am. J. Med., 58:330, 1975.PubMedCrossRefGoogle Scholar
  18. 18.
    Banatvala, J.E., Best, J.M., and Wallter, D.K. EBV-specific IgM in infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal carcinoma. Lancet, i:1205, 1972.CrossRefGoogle Scholar
  19. 19.
    Askinazi, C., Cole, F.S., and Brosch, J.L. Positive differential heterophil antibody tests — persistence in a symptomatic patient. J. Am. Med. Assoc, 236: 1492, 1976.CrossRefGoogle Scholar
  20. 20.
    Virelizier, J.L., Lenoir, G., and Griscelli, C. Persistent EBV infection in a child with hypergammaglobulinemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet, ii:231, 1978.CrossRefGoogle Scholar
  21. 21.
    Sakamoto, K., Freed, H.J., and Purtilo, D.T. Antibody responses to EBV in families with the X-linked lymphopro-liferative syndrome. J. Immunol., 125:921, 1980.PubMedGoogle Scholar
  22. 22.
    Purtilo, D.T., Paquin, L.A., Sakamoto, K., Hutt, L.M., Yang, J.P.W., Sparling, S., Beberman, N., and McAuley, R.A. Persistent transfusion associated infectious mononucleosis with transient acquired immunodeficiency. Am. J. Med., 68:437, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Masucci, M.G., Szigeti, R., Ernberg, I., Masucci, G., Klein, G., Chessel, J., Sieff, C., Lie, S., Glomstein, A., Businco, L., Henle, W., Henle, G., Pearson, G., Sakamoto, K., and Purtilo, D.T. Cellular immune defects to EBV-determined antigens in young males. Cancer Res., 41:4284, 1981.PubMedGoogle Scholar
  24. 24.
    Purtilo, D.T., Sakamoto, K., Saemundsen, A.K., Sullivan, J.L., Synnerholm, A.C., Andersson-Anvret, M., Pritchard, J., Sloper, C., Sieff, C., Pincott, J., Pachman, L., Rich, K., Cruzi, F., Cornet, J., Collins, R., Barnes, N., Knight, J., Sandstedt, B., and Klein, G. Documentation of EBV infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological and immunopathological studies. Cancer Res., 41:4226, 1981.PubMedGoogle Scholar
  25. 25.
    Tobi, M., Morag, A., Ravid, Z. et al. Prolonged atypical illness associated with serological evidence of persistent EBV infection. Lancet, i:61, 1982.CrossRefGoogle Scholar
  26. 26.
    Lennette, E.M. and Schmidt, N.J. (eds.) Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. 5th edition, pp. 441–470. Washington, D.C. American Public Health Association, 1979.Google Scholar
  27. 27.
    Schleupner, C.J. and Overall, J.C. Infectious mononucleosis and EBV. II. Clinical picture, diagnosis, management. Postgrad. Med., 65:95, 1979.PubMedGoogle Scholar
  28. 28.
    Finch, S.C. Infectious mononucleosis. In: R.L. Carter and H.G. Penman (eds.), Infectious Mononucleosis. pp. 19–46. Oxford and Edinburgh: Blackwell Scientific Publications, 1969.Google Scholar
  29. 29.
    Cadie, M., Nye, F.J., and Storey, P. Anxiety and depression after infectious mononucleosis. Brit. J. Psychiat., 128:559, 1976.PubMedCrossRefGoogle Scholar
  30. 30.
    Hendler, N. and Leary, W. Psychiatric and neurologic sequelae of infectious mononucleosis. Am. J. Psych., 135:842, 1978.Google Scholar
  31. 31.
    Evans, A.S. Epstein-Barr and infectious mononucleosis. N. Engl. J. Med., 286:836, 1972.PubMedCrossRefGoogle Scholar
  32. 32.
    Evans, A.S. Infectious mononucleosis and related syndrome. Am. J. Med. Sci., 276:325, 1978.PubMedCrossRefGoogle Scholar
  33. 33.
    Gordon, D.S., Jones, B.M., Browning, S.W., Spira, T.J., and Lawrence, D.N. Persistent polyclonal lymphocytosis of B lymphocytes. N. Engl. J. Med, 307:232 1982.PubMedCrossRefGoogle Scholar
  34. 34.
    Evans, A.S., Niderman, J.C, Cenabre, L.C., West, B., and Richards, N.A. A prospective evaluation of heterophile and EBV-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. J. Inf. Dis., 132:546, 1975.CrossRefGoogle Scholar
  35. 35.
    Henle, G., Lynette, E.T., Alspaugh, M.A., and Henle, W. Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus specific IgM antibodies. Clin. Exp. Immunol., 36:415, 1979.PubMedGoogle Scholar
  36. 36.
    Sumaya, C.V. Endogenous reactivation of Epstein-Barr virus infections. J. Inf. Dis., 135:374, 1977.CrossRefGoogle Scholar
  37. 37.
    Ross, C.A.C. and McDavid, R. Specific IgM antibody in serum of patients with herpes-zoster infections. Br. Med. J., 5:522, 1972.CrossRefGoogle Scholar
  38. 38.
    Henle, G., Henle, W., and Klein, G. Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells. Int. J. Cancer, 8:272, 1971.PubMedCrossRefGoogle Scholar
  39. 39.
    Henle, W., Ho, H.C., Henle, G., and Kwan, H.C. Antibodies to EBV-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors. J. Natl. Cancer Inst., 51: 361, 1973.PubMedGoogle Scholar
  40. 40.
    Klein, G. and Purtilo, D.T. Summary: symposium on Epstein-Barr virus induced lymphoproliferative disease in immuno-deficient patients. Cancer Res., 41:4302, 1981.PubMedGoogle Scholar
  41. 41.
    Henle, W. and Henle, G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res., 4l:4222, 1981.Google Scholar
  42. 42.
    Isaacs, R. Chronic infectious mononucleosis. Blood, 3:898, 1948.Google Scholar
  43. 43.
    Baron, S. and Dianzani, F. General consideration of the interferon system. Tex. Rep. Biol. Med., 35:1 1977.PubMedGoogle Scholar
  44. 44.
    Baglioni, C. Interferon-induced enzymatic activities and their role in the antiviral state. Cell, 17:255, 1979.PubMedCrossRefGoogle Scholar
  45. 45.
    Minks, M.A., Benvin, S., Maroney, P.A., and Baglioni, C. Synthesis of (2’–5’)-oligo (A) in extracts of interferon-treated HeLa cells. J. Biol. Chem., 254:5058, 1979.PubMedGoogle Scholar
  46. 46.
    Schattner, A., Wallach, D., Merlin, G., Hahn, T., Levin, S., and Revel, M. Assay of an interferon-induced enzyme in white blood cells as a diagnostic and in viral diseases. Lancet, ii:497, 1981.CrossRefGoogle Scholar
  47. 47.
    Morag, A., Tobi, M., Ravid, Z., Schattner, A., and Revel, M. Elevated [2’–5’]-oligo A synthetase activity in patients with prolonged illness associated with serological evidence of persistent EBV infection. Lancet, i:744, 1982.CrossRefGoogle Scholar
  48. 48.
    Harrison’s Principles of Internal Medicine. 9th Edition Eds. Isselbacher, Adams, Braunwald, Petersdorf, and Wilson. 10: Chills and Fever. R.G. Petersdorf, pp. 60–67, 1980.Google Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Martin Tobi
    • 1
  • Abraham Morag
    • 2
  1. 1.Laboratory Immunology, NCINIHBethesdaUSA
  2. 2.Division of Clinical Virology, Section of VirologyHadassah-Hebrew University Medical SchoolJerusalemIsrael

Personalised recommendations